The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers

A preliminary study of factor IX coagulant activity (FIX:C) for determining hemophilia B carriers was conducted at the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital in Bangkok. Twenty-eight females (8 obligate, 20 potential carriers) from 17 hemophilia B families were enrolled i...

Full description

Saved in:
Bibliographic Details
Main Authors: Saranya Rurgkhum, Werasak Sasanakul, Sukanya Chotsuppakarn, Pakaimas Pintadit, Ampaiwan Chuansumrit
Other Authors: Research Center
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/20338
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.20338
record_format dspace
spelling th-mahidol.203382018-07-24T10:04:42Z The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers Saranya Rurgkhum Werasak Sasanakul Sukanya Chotsuppakarn Pakaimas Pintadit Ampaiwan Chuansumrit Research Center Mahidol University Medicine A preliminary study of factor IX coagulant activity (FIX:C) for determining hemophilia B carriers was conducted at the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital in Bangkok. Twenty-eight females (8 obligate, 20 potential carriers) from 17 hemophilia B families were enrolled in the study. Additionally, 25 normal females were included. They were not pregnant and not using oral contraceptives. Then, three cut-off levels of FIX:C including 50 per cent which was the commonly used level; 57 per cent which was the mean-2 SD of normal females and 75 per cent which was the level reported by Knobe and Ljung in 1999 were used for the diagnosis of hemophilia B carriers. The sensitivities of these three cut-off levels were 12.5 per cent (1/8) for 50 per cent, 37.5 per cent (3/8) for 57 per cent and 50 per cent (4/8) for 75 per cent. Also, the specificities were 100 per cent (25/25) for both 50 and 57 per cent, and 96 per cent (24/25) for 75 per cent. Although the low cut-off levels of 50 per cent and 57 per cent had low sensitivities, they yielded a high specificity (100%) compared to the higher level of 75 per cent. In the present study, the sensitivity of the cut-off level at 75 per cent was much lower than that of the study by Knobe and Ljung (93%) since the presented sample size of obligate carriers was rather small. So, enrollment of more subjects should be further carried out. In conclusion, FIX:C determination alone showed a limitation in the diagnosis of hemophilia B carriers. The addition of genetic analysis of linkage analysis or mutation detection is required for a definite diagnosis. 2018-07-24T03:04:42Z 2018-07-24T03:04:42Z 2002-11-01 Article Journal of the Medical Association of Thailand. Vol.85, No.SUPPL. 4 (2002) 01252208 2-s2.0-0036881835 https://repository.li.mahidol.ac.th/handle/123456789/20338 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036881835&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Saranya Rurgkhum
Werasak Sasanakul
Sukanya Chotsuppakarn
Pakaimas Pintadit
Ampaiwan Chuansumrit
The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers
description A preliminary study of factor IX coagulant activity (FIX:C) for determining hemophilia B carriers was conducted at the Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital in Bangkok. Twenty-eight females (8 obligate, 20 potential carriers) from 17 hemophilia B families were enrolled in the study. Additionally, 25 normal females were included. They were not pregnant and not using oral contraceptives. Then, three cut-off levels of FIX:C including 50 per cent which was the commonly used level; 57 per cent which was the mean-2 SD of normal females and 75 per cent which was the level reported by Knobe and Ljung in 1999 were used for the diagnosis of hemophilia B carriers. The sensitivities of these three cut-off levels were 12.5 per cent (1/8) for 50 per cent, 37.5 per cent (3/8) for 57 per cent and 50 per cent (4/8) for 75 per cent. Also, the specificities were 100 per cent (25/25) for both 50 and 57 per cent, and 96 per cent (24/25) for 75 per cent. Although the low cut-off levels of 50 per cent and 57 per cent had low sensitivities, they yielded a high specificity (100%) compared to the higher level of 75 per cent. In the present study, the sensitivity of the cut-off level at 75 per cent was much lower than that of the study by Knobe and Ljung (93%) since the presented sample size of obligate carriers was rather small. So, enrollment of more subjects should be further carried out. In conclusion, FIX:C determination alone showed a limitation in the diagnosis of hemophilia B carriers. The addition of genetic analysis of linkage analysis or mutation detection is required for a definite diagnosis.
author2 Research Center
author_facet Research Center
Saranya Rurgkhum
Werasak Sasanakul
Sukanya Chotsuppakarn
Pakaimas Pintadit
Ampaiwan Chuansumrit
format Article
author Saranya Rurgkhum
Werasak Sasanakul
Sukanya Chotsuppakarn
Pakaimas Pintadit
Ampaiwan Chuansumrit
author_sort Saranya Rurgkhum
title The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers
title_short The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers
title_full The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers
title_fullStr The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers
title_full_unstemmed The limitation of factor IX coagulant activity determination in the diagnosis of hemophilia B carriers
title_sort limitation of factor ix coagulant activity determination in the diagnosis of hemophilia b carriers
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/20338
_version_ 1763497169555292160